share_log

上海君澜律师事务所关于浙江海正药业股份有限公司2021年限制性股票激励计划回购注销及解除限售相关事项之法律意见书

Legal Opinion of Shanghai Junlan Law Firm on matters relating to the repurchase and cancellation of the 2021 restricted stock incentive plan of Zhejiang Haizheng Pharmaceutical Co., Ltd.

SZSI ·  Jan 31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more